Apcalis SX

By G. Myxir. Concordia College, Austin Texas. 2019.

By law proven apcalis sx 20 mg, if you are currently insured and test positive 20 mg apcalis sx, you cannot be discharged from your insurance plan apcalis sx 20mg on-line. If you have specific questions about your policy and do not feel comfortable talking with your employer or company representative you should consider contacting the National AIDS hotline at 1-800-342-2437 (AIDS). Hotline staff will try to locate a local case manager in your area who can help you investigate your plan. You may find that your health plan has a cap on annual medication costs. For some people who do not have adequate prescription drug coverage, there is a federal program called the AIDS Drug Assistance Program (ADAP). ADAP was designed to provide access to expensive HIV medications for people who are considered to be underinsured or have no insurance. Eligibility for ADAP is determined based on your financial situation. Eligibility will also vary from state to state, as will the number of medications covered. States with larger numbers of people living with HIV tend to have a larger list of covered medications. If you are currently unemployed or have a low income, you may be eligible for Medicaid. Medicaid is a federal program that provides health care for people who cannot afford to purchase insurance on their own. If you qualify for supplemental security income (SSI), you will automatically receive Medicaid. In order to transmit HIV, there must be an exchange of body fluids, blood, semen, vaginal secretions, or breast milk. HIV is often transmitted through unprotected sexual contact. Using condoms will significantly reduce the risk of transmitting HIV to a sexual partner. If you are using intravenous drugs, do not share needles with others. HIV can be transmitted through breast milk, therefore new mothers are advised against breast-feeding. Women who are pregnant can take medications to reduce the risk of transmission to their child. We are learning more each day about HIV and its treatment. Evaluate which methods of information gathering work best for you. Many people living with HIV continue to lead active lives after they are diagnosed. By working closely with your doctor and leading a healthy lifestyle, you can continue to lead a happy and productive life. Cynthia Teeters is a social worker with The Center for Special Studies AIDS program at New York Presbyterian Hospital, Weill Cornell Center. Teeters has provided individual and family counseling to a diverse population of HIV positive patients, both in the hospital and in a clinic setting. Sandor Gardos, the founder and President of MyPleasure, is more than just the head of a successful sex-toy company. A licensed clinical psychologist and board-certified sexologist, Dr. Gardos has seen thousands of patients whose concerns run the full gamut of human sexual experience, from both the clinical and emotional sides of sexuality. The author of over 100 articles, chapters, presentations, books and other publications, Dr. Can you tell us a little bit about some of the more common ones? ANSWER: Basically, you can divide or classify most sexual disorders into one of several groups: Erectile dysfunctions are any disorder in which a man has a problem obtaining or maintaining an erection. Finally, there are desire disorders in which a man just does not feel "horny" or does not want to have sex. Click or Scroll for More ContentEach of these disorders can be caused by physical, medical, pharmacological or psychological conditions -- or all of the above. In fact, men most often experience a combination of several different conditions and dysfunctions, and it is not unusual for one form of sexual dysfunction to lead to the other. Many of these disorders can also be a sign of another illness, such as diabetes. So the first step is always to make sure there is no physical problem. As with any medical condition, it is important that men speak to their physicians about any kind of sexual dysfunction. Even if the doctor thinks it is probably psychological, a physical condition can also contribute to the problem. QUESTION: Traditionally, only women have been thought to suffer from lack of sexual desire. ANSWER: In our society, it is often thought that men are always ready, able and willing to have sex at any time, with anyone. The reality is that everyone has different "appetites" when it comes to sex, just as they do with food. We think of this situation as lack of sexual desire, low libido or decreased sex drive. Lack of sexual desire only becomes a problem when the man or his partner is unhappy with the situation, or what is known as a "desire discrepancy," the number-one condition seen by sex therapists. As most therapists will tell you, it is equally common for the man or the woman to be the one with lower desire. Remember, there is no "correct" amount of sex to have or desire. Yes, there are norms, but what really matters is whether you and your partner are in harmony about how often you have sex. QUESTION: I know many therapists differ in their views on sexual addiction. Do you consider sexual addiction a form of sexual dysfunction? Like many sexologists, I do not subscribe to the concept of sexual "addiction. To say that someone who masturbates ten times a day is an "addict" is a moral judgment, not a scientific one. Similarly, someone who has sex twice a day can be just as healthy as someone who has sex once a week. Those little "tests" you see that claim to tell you whether you are a sex addict are worthless.

apcalis sx 20mg with visa

They probably thought I was off having the time of my life at school and when I told them what was really going on I think it really shocked them apcalis sx 20 mg low cost. I think that not seeing me in the middle of "it" might have made it harder for them to understand what I was going through order 20 mg apcalis sx. But when I was having a hard time after my junior year and then again after I graduated my parents were there for me 20mg apcalis sx sale. They were very supportive and tried to get me whatever help they could. Was recovering from panic disorder and depression easy, hard, extremely difficult? On the scale of difficulty, where did it lie for you? Samantha Schutz: I think recovery is a great way to describe what I have gone through in the last few years. For the last few years, whenever I tried to talk about my experience with anxiety disorder, I ran into the same problem. Trying to find the right verb was more than just semantics. For many years, having an anxiety disorder shaped nearly every bit of my life- where I went, who I went with, how long I stayed. I do not believe that anxiety disorder can be flipped off like a switch, and accordingly, simply using past or present tense did not accurately reflect how I was feeling. The body has an unbelievable capacity to remember pain, and my body was not ready to forget what I had been through. It was only about a year ago that I settled on saying, "I am in recovery from anxiety disorder. Since that fall, I have seen more than a half dozen therapists and taken as many different medications. I have been to yoga and meditation classes, swung tennis rackets at pillows, practiced the art of breathing, tried hypnosis, and taken herbal remedies. Sometimes things were bad and I had several panic attacks a day. I just had to always remember that panic attacks always end and that bad days and bad weeks always end too. Natalie: You tried different treatments, different medications. What motivated you to continue on with seeking treatment? There were sometimes when things looked pretty bleak... That even though things are pretty bad, there is something they are getting out of feeling bad. There have been a few times that I have felt really depressed and I wanted to feel depressed. I think that at some point I decided I really wanted to get better and that was a sort of turning point for me and I started making more progress. Natalie: One last question before we turn to some audience questions: You mentioned at the beginning that you are stable and better able to live your life. Are you ever afraid that the anxiety and panic attacks and depression will return? I am still on medication and I wonder what will happen when I go off it. At the end of my book there is a poem that says a lot about how I felt on this subject. Keep in mind that this poem reflects how I felt several years ago. That it was close, but that all of the work I was doing (the meds, the therapy) was helping to keep it at bay. I think it could take me a lifetime to figure out how things are different, but even then, is it important to know? I will never know for sure what is different about me. Natalie: Thanks Samantha, here are some more questions from the audience. I have read many books and it seems I experience symptoms that are not common. There were times I thought I had some weird illness. There are so many different symptoms and so many different ways that people feel. Samantha Schutz: I think that for a long time I just left where ever I was if I was having a panic attack. I did feel bad that I was putting my friends out and that they left all sorts of places because of me. I can now do without any hesitation, but I am still on Xanax. Do you think there is anything wrong with having to take medication to enjoy doing things? I remember when I was first thinking about going on medication I was hesitant. The psychiatrist asked me if I would have trouble taking medication if I was diabetic. Others where I could not swallow the pill fast enough. I have been on meds for a long time and am wondering if I should go off. This does not sound like one decision you should or can make alone. How would someone like me cope with this and how did you? Samantha Schutz: There is a type of therapy called CBT: Cognitive Behavioral Therapy This therapy is all about teaching you specific ways to deal with specific problems. In CBT a patient might do a lot of breath work on learning how to breathe in a way that will help you calm down. But I can only speak from my own personal experience. I have a medication phobia among many others (bridges, crowds, elevators, etc. There were also a lot of places I avoided and things that I hated doing because I would have panic attacks. These therapies give you strategies to deal with your fears.

Similar studies have not been conducted in nursing mothers apcalis sx 20 mg. Because the potential for hypoglycemia in nursing infants may exist 20mg apcalis sx otc, a decision should be made whether to discontinue nursing or to discontinue Metaglip discount 20mg apcalis sx with mastercard, taking into account the importance of the drug to the mother. If Metaglip is discontinued, and if diet alone is inadequate for controlling blood glucose, insulin therapy should be considered. Safety and effectiveness of Metaglip in pediatric patients have not been established. Of the 87 patients who received Metaglip in the second-line therapy trial, 17 (19. No overall differences in effectiveness or safety were observed between these patients and younger patients in either the initial therapy trial or the second-line therapy trial, and other reported clinical experience has not identified differences in response between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Metformin hydrochloride is known to be substantially excreted by the kidney and because the risk of serious adverse reactions to the drug is greater in patients with impaired renal function, Metaglip should only be used in patients with normal renal function (see CONTRAINDICATIONS, WARNINGS, and CLINICAL PHARMACOLOGY: Pharmacokinetics). Because aging is associated with reduced renal function, Metaglip should be used with caution as age increases. Care should be taken in dose selection and should be based on careful and regular monitoring of renal function. Generally, elderly patients should not be titrated to the maximum dose of Metaglip (see also WARNINGS and DOSAGE AND ADMINISTRATION ). In a double-blind 24-week clinical trial involving Metaglip as initial therapy, a total of 172 patients received Metaglip 2. The most common clinical adverse events in these treatment groups are listed in Table 4. Table 4: Clinical Adverse Events >5% in any Treatment Group, by Primary Term, in Initial Therapy StudyUpper respiratory infectionIn a double-blind 18-week clinical trial involving Metaglip as second-line therapy, a total of 87 patients received Metaglip, 84 received glipizide, and 75 received metformin. The most common clinical adverse events in this clinical trial are listed in Table 5. Table 5: Clinical Adverse Events >5% in any Treatment Group, by Primary Term, in Second-Line Therapy StudyThe dose of glipizide was fixed at 30 mg daily; doses of metformin and Metaglip were titrated. In a controlled initial therapy trial of Metaglip 2. In a controlled second-line therapy trial of Metaglip 5 mg/500 mg, the numbers of patients with hypoglycemia documented by symptoms and a fingerstick blood glucose measurement ?-T50 mg/dL were 0 (0%) for glipizide, 1 (1. Gastrointestinal symptoms of diarrhea, nausea/vomiting, and abdominal pain were comparable among Metaglip, glipizide and metformin in the second-line therapy trial. Overdosage of sulfonylureas, including glipizide, can produce hypoglycemia. Mild hypoglycemic symptoms, without loss of consciousness or neurological findings, should be treated aggressively with oral glucose and adjustments in drug dosage and/or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medical emergencies requiring immediate hospitalization. If hypoglycemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dL. Patients should be closely monitored for a minimum of 24 to 48 hours, since hypoglycemia may recur after apparent clinical recovery. Clearance of glipizide from plasma would be prolonged in persons with liver disease. Because of the extensive protein binding of glipizide, dialysis is unlikely to be of benefit. Overdose of metformin hydrochloride has occurred, including ingestion of amounts >50 g. Hypoglycemia was reported in approximately 10% of cases, but no causal association with metformin hydrochloride has been established. Lactic acidosis has been reported in approximately 32% of metformin overdose cases (see WARNINGS ). Metformin is dialyzable with a clearance of up to 170 mL/min under good hemodynamic conditions. Therefore, hemodialysis may be useful for removal of accumulated drug from patients in whom metformin overdosage is suspected. Dosage of Metaglip must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended daily dose of 20 mg glipizide/2000 mg metformin. Metaglip should be given with meals and should be initiated at a low dose, with gradual dose escalation as described below, in order to avoid hypoglycemia (largely due to glipizide), reduce GI side effects (largely due to metformin), and permit determination of the minimum effective dose for adequate control of blood glucose for the individual patient. With initial treatment and during dose titration, appropriate blood glucose monitoring should be used to determine the therapeutic response to Metaglip and to identify the minimum effective dose for the patient. Thereafter, HbAshould be measured at intervals of approximately 3 months to assess the effectiveness of therapy. The therapeutic goal in all patients with type 2 diabetes is to decrease FPG, PPG, and HbAto normal or as near normal as possible. Ideally, the response to therapy should be evaluated using HbA, which is a better indicator of long-term glycemic control than FPG alone. No studies have been performed specifically examining the safety and efficacy of switching to Metaglip therapy in patients taking concomitant glipizide (or other sulfonylurea) plus metformin. Changes in glycemic control may occur in such patients, with either hyperglycemia or hypoglycemia possible. Any change in therapy of type 2 diabetes should be undertaken with care and appropriate monitoring. For patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone, the recommended starting dose of Metaglip is 2. For patients whose FPG is 280 mg/dL to 320 mg/dL a starting dose of Metaglip 2. The efficacy of Metaglip in patients whose FPG exceeds 320 mg/dL has not been established. Dosage increases to achieve adequate glycemic control should be made in increments of 1 tablet per day every 2 weeks up to maximum of 10 mg/1000 mg or 10 mg/2000 mg Metaglip per day given in divided doses. In clinical trials of Metaglip as initial therapy, there was no experience with total daily doses >10 mg/2000 mg per day. For patients not adequately controlled on either glipizide (or another sulfonylurea) or metformin alone, the recommended starting dose of Metaglip is 2. In order to avoid hypoglycemia, the starting dose of Metaglip should not exceed the daily doses of glipizide or metformin already being taken.

best apcalis sx 20mg

An important gap in knowledge concerns the role of diet composition in energy balance purchase 20mg apcalis sx fast delivery. Popular diets low in carbohydrates have been purported to enhance weight loss order apcalis sx 20 mg visa. Shorter-term clinical studies show equivocal results discount apcalis sx 20mg line. In addition, mechanisms by which popular diets affect energy balance, if at all, are not well understood. Although numerous animal studies assessing the impact of diet composition on appetite and body weight have been conducted, these studies have been limited by availability and use of well-defined and standardized diets. The research on weight loss is more abundant than that on weight maintenance. Many clinical studies of dietary supplements are flawed because of inadequate sample size, poor design, limited preliminary dosing data, lack of blinding even when feasible, and/or failure to incorporate objective or standardized outcome instruments. In addition, the lack of reliable data on the absorption, disposition, metabolism, and excretion of these entities in living systems has complicated the selection of products to be used in clinical trials. This is more problematic for complex preparations (e. The lack of consistent and reliable botanical products represents a formidable challenge both in clinical trials and in basic research. Most have not been sufficiently characterized or standardized for the conduct of clinical trials capable of adequately demonstrating safety or efficacy, or predicting that similarly prepared products would also be safe and effective in wider public use. Consequently, obtaining sufficient quantities of well-characterized products for evaluation in clinical trials would be advantageous. Several issues regarding the choice of clinical trial material require special attention, for example:Influences of climate and soilUse of different parts of the plantsUse of different cultivars and speciesOptimal growing, harvesting, and storage conditionsUse of the whole extract or a specific fractionChemical standardization of the productBioavailability of the formulationDose and length of administrationSome nonbotanical dietary supplements, such as vitamins, carnitine, glucosamine, and melatonin, are single chemical entities. Their putative active ingredients may be identified, but are rarely known for certain. Usually, there is more than one of these ingredients, often dozens. When active compounds are unknown, it is necessary to identify marker or reference compounds, even though they may be unrelated to biological effects. Qualitative and quantitative determinations of the active and marker compounds, as well as the presence of product contaminants, can be assessed by capillary electrophoresis, gas chromatography, liquid chromatography-mass spectrometry, gas chromatography-mass spectrometry, high-performance liquid chromatography, and liquid chromatography-multidimensional nuclear magnetic resonance. Fingerprinting techniques can map out the spectrum of compounds in a plant extract. New applications of older techniques and new analytical methods continue to be developed and validated. However, there remains a paucity of analytical tools that are precise, accurate, specific, and robust. Steps are currently being taken to apply molecular tools, such as DNA fingerprinting, to verify species in products, while transient expression systems, and microarray and proteomic analyses, are beginning to be used to define the cellular and biological activities of dietary supplements. Particular attention should be paid to the issues of complex botanicals and clinical dosing. Quality control of complex botanicals is difficult, but must be accomplished, because it is not ethical to administer an unknown product to patients. The use of a suboptimal dose that is safe but ineffective does not serve the larger goals of NCCAM, the CAM community, or public health. Although the trial would indicate only that the tested dose of the intervention was ineffective, the public might conclude that all doses of the intervention are ineffective, and patients would be denied a possible benefit from the intervention. Overdosing, on the other hand, might produce unnecessary adverse effects. Phase I/II studies should be conducted first to determine the safety of various doses, and the optimal dose should then be tested in a phase III trial. As a result, maximum benefit would be seen in the trial; also, any negative result would be definitive. To a great extent, the difference between a dietary supplement and a drug lies in the use of the agent, not in the nature of the agent itself. If an herb, vitamin, mineral, or amino acid is used to resolve a nutritional deficiency or to improve or sustain the structure or function of the body, the agent is considered a dietary supplement. If the agent is used to diagnose, prevent, treat, or cure a disease, the agent is considered a drug. This distinction is key when the FDA determines whether proposed research on a product requires an investigational new drug (IND) exemption. If the proposed investigation of a lawfully marketed botanical dietary supplement is to study its effects on diseases (i. The FDA has worked with NCCAM to provide direction to investigators and recently created a Botanical Review Team to ensure consistent interpretation of the document Guidance for Industry--Botanical Drug Products. Such FDA guidance is currently unavailable for other products (e. Similarly, little attention has been paid to the quality of probiotics. Quality issues for probiotic supplements may include:Viability of bacteria in the productTypes and titer of bacteria in the productStability of different strains under different storage conditions and in different product formatsEnteric protection of the productTherefore, for optimal studies, documentation of the type of bacteria (genus and species), potency (number of viable bacteria per dose), purity (presence of contaminating or ineffective microorganisms), and disintegration properties must be provided for any strain to be considered for use as a probiotic product. Speciation of the bacteria must be established by means of the most current, valid methodology. Many of the challenges identified for research on dietary supplements, including issues of composition and characterization, are applicable to research on functional foods and whole diets. In addition, challenges of popular diet research include adherence to the protocol for longer-term studies, inability to blind participants to intervention assignment, and efficacy versus effectiveness. Over the past few decades, thousands of studies of various dietary supplements have been performed. To date, however, no single supplement has been proven effective in a compelling way. Nevertheless, there are several supplements for which early studies yielded positive, or at least encouraging, data. Good sources of information on some of them can be found at the Natural Medicines Comprehensive Database and a number of National Institutes of Health (NIH) Web sites. The NIH Office of Dietary Supplements (ODS) annually publishes a bibliography of resources on significant advances in dietary supplement research. Finally, the database lists all NIH-supported clinical studies of dietary supplements that are actively accruing patients. For example, multicenter trials have concluded or are in progress on ginkgo (Ginkgo biloba) for prevention of dementia, glucosamine hydrochloride and chondroitin sulfate for osteoarthritis of the knee, saw palmetto (Serenoa repens)/African plum (Prunus africana) for benign prostatic hypertrophy, vitamin E/selenium for prevention of prostate cancer, shark cartilage for lung cancer, and St. The results of one of the depression studies showed that St. Other studies of this herb, including its possible value in treatment of minor depression, are under way. Reviews of the data regarding some dietary supplements have been conducted, including some by the members of the Cochrane Collaboration.

This page assumes that the depressed person has been diagnosed and is in treatment order 20 mg apcalis sx overnight delivery. I commend you for taking an interest in a very difficult subject and for wishing to help 20mg apcalis sx sale. Pardon my bluntness order apcalis sx 20 mg fast delivery, but there are a few things you really need to know, before you get too far into this subject. It is not just sadness which can be waved off with a few kind words. If you are going into this with the heroic notion that you can somehow "fix" it for your friend, spouse or relative, then you need to disavow it immediately. Operating on this assumption will only frustrate you and does no one any good. Your friend or relative is going to go on the decline, now and then. The "roller-coaster" effect is just a part and parcel of depression. Sincerity will help him or her a great deal; it will engender trust, which every depression patient has a problem with, at one time or another. No one wants to make your life miserable by being depressed. Recovery from depression is not just a matter of taking anti-depressant medication and going to therapy. Treatment involves a lot of fundamental changes in a person. Believe me, it is--the depression probably hid the "real person" from your view, up to the point that he or she was diagnosed and began treatment. At times, it may seem that the person is actually pushing you away. Most depression patients believe that they unduly affect those around them and will do anything to prevent that from happening. This kind of self-sabotage is actually a symptom of the illness itself. Try to understand that this is often involuntary and irrational, and act accordingly. I cannot tell you precisely what is best for your friend, spouse or relative. Make the question open-ended, so the person can say what he or she wants, but provide something specific for them to talk about. He or she will want to isolate themselves--hibernate, even--but this is exactly what should not happen. Take walks, go shopping, go to a movie, whatever you have to, to get the person out of the environment they are trying to take shelter in. You may get some resistance, and even complaints; be persistent but not unreasonable. Even if they mention self-injury, or they are suicidal, you are not endangering them by listening. Actually, you are helping to protect them from those things; talking helps them deal with these feelings. These can include appetite, sleep habits, drinking or drug abuse, anything at all. Little things go a long way for someone with clinical depression. Small gifts and favors seem much bigger to them than to you. Even if it seems silly or hokey, small considerations will help. There are a couple of web pages which speak to this issue better than I can. Non-depressed people have a difficult time understanding depression; which is completely understandable. Depression is not a weakness, character flaw, personality trait, or anything of that kind. And you did nothing to cause someone in your life to become clinically depressed. In fact, many depression patients experience numbness, or no emotion, rather than sadness. Point out any transgressions and explain what went wrong, and make sure the person understands it. However, getting angry or vindictive do no good, either. And stick by your friend or relative; you will find that it pays off in the end. Go here for a more in-depth look at depression and supporting a depressed person. Just as any depression patient must learn to accept his or her illness, and work on overcoming it, so you must accept that they have a mood disorder. If you need to, take some time away from the depressed person. It will give you a better perspective on things and unravel frustrations and tensions. Any child old enough to form a relationship will experience some form of grief when a relationship is severed. Adults may not view a child behavior as grief as it is often demonstrated in behavioral patterns which we misunderstand and do not appear to us to be grief such as "moody," "cranky," or "withdrawn. This may be a tall order to expect of the adults who are experiencing their own grief and upset. Caring adults can guide children through this time when the child is experiencing feelings for which they have no words and thus can not identify. In a very real way, this time can be a growth experience for the child, teaching about love and relationships. This means that they should be allowed to participate in any of the arrangements, ceremonies and gatherings which are comfortable for them. First, explain what will be happening and why it is happening at a level the child can understand. Be aware that children will probably have short attention spans and may need to leave a service or gathering before the adults are ready. Many families provide a non-family attendant to care for the children in this event. The key is to allow the participation, not to force it. Children instinctively have a good sense of how involved they wish to be. Someone you know may be experiencing grief - perhaps the loss of a loved one, perhaps another type of loss - and you want to help.

apcalis sx 20 mg on line

So buy apcalis sx 20 mg line, wanting to share with other people these inner feelings and these inner thoughts is one way of becoming open generic apcalis sx 20mg without prescription. What you share about yourself should encourage others to come in 20 mg apcalis sx for sale, so to speak, and make contact with you. It makes us feel vulnerable, psychologically naked and usually anxious. But it also is important in terms of really letting others get to understand how we think, how we feel and what we believe. But we also shut out other people from knowing and accepting us by not being open. Telling somebody where you bought those new pair of shoes might be one way of being open. However, it might be more meaningful to share why clothes are important to you. What is it about those pair of shoes that is important to you? That puts the conversation on a little deeper level. There are risks attached to sharing that information. Most important is an immediate here-and-now honesty that goes along with being open. It would be more honest and open to share that resentment openly with the person and that way the situation and your feelings can be changed. And when you are open and honest about negative feelings, it also makes you responsible for suggesting alternatives to change those feelings. You have the power to change things by being open and sharing things. Keep in mind also that being completely open with everyone in every situation may be very inappropriate. Also, some people may be very uncomfortable with too much openness and you may not want to be as open with them. Openness is making your outer world as similar to your inner world as possible. That is letting what shows, your expression, frown, words represent what you actually feel and think. In the name of being open we say everything we feel or think to others, but fail to be sensitive to others feelings about our openness. We may make them feel very uncomfortable or say something that hurts them. Being open also carries a responsibility with it and that is to be aware of others reactions to us and to respect their reactions. This may mean not disclosing everything with some people out of respect for their feelings. Being Open is a Two-Way Street" />Becoming open also means becoming open to what others are saying and sharing about themselves. An example is someone talking about doing badly on a test. Try to be open to what that person is sharing about their feelings. By building mutual trust, you and your listener will share a great deal more. You will not share your feelings or thoughts too quickly and thereby push your listener away. You will not have someone listen to you too long, without giving them hints about the kind of listener you want them to be. Make your outside behavior the same or congruent with your inside feelings and thoughts. However, if we work really hard and try to understand the hurt, if we share the hurt and are open about the hurt, we are actually being more open at a deeper level. Change your questions into statements you can make about yourself. Decide what it is and whether you can really trust it with the other person or persons. Keep in mind that some ways of being open are more appropriate and helpful than others. Both are certainly ways of being open about the anger. However, if other people are with you, talking to them about your anger is probably easier for them than ducking from a book you just threw towards them. Finally, the extent to which others are open with you will depend on how open you are with them. Many people discover that as a relationship develops, openness is reciprocated and the relationship becomes more meaningful. When we stay open to learning, new experiences open up for us. How you resolve relationship problems will help determine the quality of your relationship. Here are some excellent suggestions for dealing with relationship issues. Often, this is because people have conflicting expectations, are distracted with other issues, or have difficulty expressing what is on their minds in ways that other people can really hear and understand what is being said. The following information covers ways of enhancing relationships and working with common problems. This does not necessarily mean agreeing with one another all the time. Realistically, no two people will agree on all occasions. Insisting that your partner spend all of his or her time with you, insisting that they give up their friends or that you both hang around only your friends, insisting that you give approval of the clothes they wear, making sure that you make all the decisions about how you spend you time together and where you go when you go out, making them feel guilty when they spend time with their families, making sure you win all the arguments, always insisting that your feelings are the most important... An example might be when want your partner to show love for you by spending free time with you, sharing and being open, paying attention to your concerns and needs. Time spent apart and time spent together is another common relationship concern. You may enjoy time together with your partner and your partner may want some time together with you, but you also may enjoy time alone, or with other friends. Check out with your partner what time alone means and share your feelings about what you need from the relationship in terms of time together.

...or by Phone or Mail

Lansky Sharpeners

PO Box 800
Buffalo, NY 14231 USA

Phone 716-877-7511
Fax 716-877-6955
Toll free 1-800-825-2675

Hours 8:30 am 5:00 pm EST M-F